Pulmonary Rehabilitation for Post-COVID-19

Aljazeeri, Jafar; Almusally, Rayyan; Wert, Yijin; Abdelhalim, Mostafa; Klinger, C.; Ramesh, Navitha; Rahman, Taj

doi:10.1097/hcr.0000000000000813

Cited by 3 publications

(1 citation statement)

References 38 publications

(66 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Pulmonary rehabilitation showed a promising positive effect on long COVID patients. 49 , 50 A Systematic Review and Meta‐Analysis showed that pulmonary rehabilitation could improve exercise capacity measured by 6MWD among patients with mild‐to‐moderate lung impairment after COVID‐19. 51 In patients with long COVID, exercise capacity, functional status, dyspnoea, fatigue and quality of life improved after 6 weeks of personalized interdisciplinary pulmonary rehabilitation.…”

Section: Role Of Pulmonary Rehabilitation In Long Covidmentioning

confidence: 99%

Emerging trends in management of long COVID with a focus on pulmonary rehabilitation: A review

Li,

2024

Clinical Respiratory J

View full text Add to dashboard Cite

Long COVID, or post‐acute sequelae of COVID‐19 (PASC), represents a complex condition with persistent symptoms following SARS‐Cov‐2 infection. The symptoms include fatigue, dyspnoea, cognitive impairment, decreased quality of life in variable levels of severity. Potential mechanisms behind long COVID include vascular damage, immune dysregulation and viral persistence. Diagnosing long COVID involves medical evaluation by multidisciplinary team and assessment of persistent symptoms with scoring systems in development. Treatment strategies are symptom‐focused, encompassing multidisciplinary care, rehabilitation and tailored exercise programmes. Pulmonary rehabilitation, an effective and critical component of long COVID management, has shown promise, particularly for patients with respiratory symptoms such as dyspnoea. These programmes, which combine exercise, breathing techniques, education and psychological support, improve symptoms, quality of life and overall recovery. Innovative technologies, such as telemedicine, wearable devices, telerehabilitation, are transforming long COVID management. Telemedicine facilitates consultations and interventions, eliminating healthcare access barriers. Wearable devices enable remote and continuous monitoring of patients during their rehabilitation activities. Telerehabilitation has proven to be safe and feasible and to have high potential for COVID‐19 recovery. This review provides a concise overview of long COVID, encompassing its definition, prevalence, mechanisms, clinical manifestations, diagnosis and management approaches. It emphasizes the significance of multidisciplinary approach in diagnosis and treatment of long COVID, with focus on pulmonary rehabilitation and innovative technology advances to effectively address the management of long COVID.

show abstract

Section: Role Of Pulmonary Rehabilitation In Long Covidmentioning

confidence: 99%

Emerging trends in management of long COVID with a focus on pulmonary rehabilitation: A review

Li,

2024

Clinical Respiratory J

View full text Add to dashboard Cite

show abstract

Improvements in Dyspnea Following Traditional Pulmonary Rehabilitation in Patients With Long COVID

Buckley,

Wycoff,

Mahoney

et al. 2024

Journal of Cardiopulmonary Rehabilitation and Prevention

View full text Add to dashboard Cite

Dyspnea in COVID-associated lung disease

Fan,

Nekludova,

Avdeev

2024

Medicinskij sovet

View full text Add to dashboard Cite

Introduction. Covid-associated lung disease has become one of the leading problems of the COVID-19 pandemic, and early diagnosis of complications is complicated. Assessment of dyspnoea as a significant symptom is important, but its diagnostic ability in this lesion is poorly understood.Aim. To study the features of dyspnoea in COVID-19-associated lung lesions and its diagnostic value.Materials and methods. The study included 134 patients with COVID-19-confirmed pneumonia. Demographic and anthropometric data, subjective condition, dyspnoea severity according to Borg scale, concomitant pathologies, multispiral computed tomography (MSCT) data, arterial blood gas composition, capnometry and spirometry data, as well as disease outcomes (transfer to ICU, support ventilation, fatal outcome) were analysed.Results. Dyspnoea was present in 43.3% of patients. Increased dyspnoea was associated with increased C-reactive protein (CRP), D-dimer, lung tissue damage (MSCT), decreased forced vital capacity (FVC), and increased alveolar-arterial gradient (P(A-a)O2). Dyspnoea correlated with duration of hospitalisation and need for oxygen therapy (OR = 1.307, p = 0.008). 57.4% of patients with hypoxaemia did not complain of dyspnoea, but their outcomes did not differ between patients with dyspnoea and hypoxaemia. 32.2% of patients without hypoxaemia complained of dyspnoea. These patients did not have a significant increase in FGEF by the time of discharge, and it remained lower than in patients without dyspnoea and hypoxaemia.Conclusion. Dyspnoea in COVID-19-associated lung disease is an important symptom correlating with clinical-functional, instrumental and laboratory characteristics of the disease. Comprehensive data analysis is necessary to identify patients requiring further observation.

show abstract

Pulmonary Rehabilitation for Post-COVID-19

Cited by 3 publications

References 38 publications

Emerging trends in management of long COVID with a focus on pulmonary rehabilitation: A review

Emerging trends in management of long COVID with a focus on pulmonary rehabilitation: A review

Improvements in Dyspnea Following Traditional Pulmonary Rehabilitation in Patients With Long COVID

Dyspnea in COVID-associated lung disease

Contact Info

Product

Resources

About